- Home
- GDTC vs HOOK Comparison
GDTC vs HOOK Comparison
Compare GDTC & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- HOOK
- Stock Information
- Founded
- GDTC 2018
- HOOK 2011
- Country
- GDTC Singapore
- HOOK United States
- Employees
- GDTC N/A
- HOOK N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- GDTC Health Care
- HOOK Health Care
- Exchange
- GDTC Nasdaq
- HOOK Nasdaq
- Market Cap
- GDTC 33.4M
- HOOK 30.2M
- IPO Year
- GDTC 2023
- HOOK 2019
- Fundamental
- Price
- GDTC $2.37
- HOOK $2.00
- Analyst Decision
- GDTC Buy
- HOOK Strong Buy
- Analyst Count
- GDTC 1
- HOOK 4
- Target Price
- GDTC $5.00
- HOOK $34.50
- AVG Volume (30 Days)
- GDTC 24.9K
- HOOK 66.7K
- Earning Date
- GDTC 01-01-0001
- HOOK 11-14-2024
- Dividend Yield
- GDTC N/A
- HOOK N/A
- EPS Growth
- GDTC N/A
- HOOK N/A
- EPS
- GDTC N/A
- HOOK N/A
- Revenue
- GDTC $330,254.00
- HOOK $49,999,000.00
- Revenue This Year
- GDTC $14.71
- HOOK $147.52
- Revenue Next Year
- GDTC N/A
- HOOK N/A
- P/E Ratio
- GDTC N/A
- HOOK N/A
- Revenue Growth
- GDTC N/A
- HOOK 143.30
- 52 Week Low
- GDTC $1.20
- HOOK $1.88
- 52 Week High
- GDTC $5.50
- HOOK $11.30
- Technical
- Relative Strength Index (RSI)
- GDTC 45.29
- HOOK 26.63
- Support Level
- GDTC $2.43
- HOOK $2.01
- Resistance Level
- GDTC $3.00
- HOOK $2.27
- Average True Range (ATR)
- GDTC 0.41
- HOOK 0.18
- MACD
- GDTC -0.03
- HOOK 0.02
- Stochastic Oscillator
- GDTC 21.60
- HOOK 31.94
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.